{"id":"W3202997693","doi":"10.1016/j.ejca.2021.08.013","title":"Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Internal medicine; Post-hoc analysis; Melanoma; Gastroenterology; Surgery; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002177639,0.0002143276,0.0004815917,0.0001809801,0.00003845645,0.00004211928,0.00009819756,0.00002141692,0.0002251293],"category_scores_gemma":[0.00003646106,0.0001448859,0.00006277602,0.0002602531,0.0001026517,0.0002680203,0.00003443218,0.0003150249,0.000001566458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001968406,"about_ca_system_score_gemma":0.0004132396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004034142,"about_ca_topic_score_gemma":0.0003416376,"domain_scores_codex":[0.99838,0.0001780369,0.0004904011,0.0002294677,0.0004399854,0.0002821058],"domain_scores_gemma":[0.9990241,0.00003422714,0.0002834335,0.0002018199,0.0002477101,0.0002087405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03621934,0.0003856194,0.9173668,0.00008204118,0.0001744007,0.00325845,0.0002682947,0.00005599589,0.0001105178,0.000001483444,0.00007758959,0.04199947],"study_design_scores_gemma":[0.03762655,0.001355502,0.9574788,0.001389676,0.00009669236,0.00005069033,0.00004584237,0.000003948855,0.0002233267,0.000001696288,0.001536642,0.0001906791],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935371,0.004550844,0.00002829012,0.0007475695,0.0001514009,0.0002067683,0.00002732369,0.00000707816,0.0007436132],"genre_scores_gemma":[0.9975908,0.0007531983,0.0001382282,0.0007385174,0.00009632441,0.000003838834,0.00001281603,0.00005084031,0.0006154562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04180879,"threshold_uncertainty_score":0.5908274,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01057411755757271,"score_gpt":0.2682504746834606,"score_spread":0.2576763571258879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}